Tricyclic compounds having cytostatic and/or cytotoxic...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01) C07D 239/70 (2006.01)

Patent

CA 2698018

The present invention provides tricyclic compounds having cytostatic and cytotoxic activity in a single molecule having receptor tyrosine kinase(s), dihydrofolate reductase, thymidylate synthase and/or dihydroorotate dehydrogenase inhibitory activity, which are useful as anti-angiogenic and anti-tumor agents. Also provided are methods of utilizing these inhibitors to treat tumor cells and other proliferative diseases and disorders.

La présente invention propose des composés tricycliques ayant une activité cytostatique et cytotoxique en une seule molécule ayant une activité d'inhibition du récepteur de la ou des tyrosine kinase(s), de la dihydrofolate réductase, de la thymidylate synthase et/ou de la dihydroorotate déhydrogénase, qui s'utilisent en tant qu'agents anti-angiogenèses et anti-tumoraux. L'invention propose également des procédés d'utilisation de ces inhibiteurs pour traiter des cellules tumorales et d'autres maladies et troubles prolifératifs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic compounds having cytostatic and/or cytotoxic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic compounds having cytostatic and/or cytotoxic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds having cytostatic and/or cytotoxic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1724379

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.